MedTrace Logo

Cardiac MRI for Patients Enrolled in INFUSE-AMI

NCT01059214 · Status: COMPLETED · Type: OBSERVATIONAL · Enrollment: 455

Last updated 2019-09-13

No results posted yet for this study

Summary

Background:

* INFUSE AMI is an ongoing clinical trial examining how patients with heart attacks are treated. The study's aim is to help determine the best way to treat patients with specific kinds of heart attacks caused by blood clots.
* To evaluate the effect of the heart attack on the heart tissue and function, participants in the INFUSE-AMI study will have magnetic resonance imaging (MRI) scans of the heart at specific times after their heart attack.

Objectives:

\- To perform cardiac MRI scans on patients who are participating in the INFUSE-AMI study.

Eligibility:

\- Individuals at least 18 years of age who are enrolled in the INFUSE-AMI study.

Design:

* Participants will have an MRI scan of the heart about 5 days and between 23 and 44 days after their heart attack. The MRI scan at day 5 is optional.
* Participants will provide a blood sample prior to the MRI scan.
* During the scan, participants will be given a contrast drug to show the blood flow to and within the heart. An electrocardiogram will be used to monitor the heart during the procedure.
* No other treatment will be provided in this protocol.

Conditions

Sponsors & Collaborators

  • National Heart, Lung, and Blood Institute (NHLBI)

    lead NIH

Principal Investigators

  • Andrew E Arai, M.D. · National Heart, Lung, and Blood Institute (NHLBI)

Eligibility

Min Age
18 Years
Sex
ALL
Healthy Volunteers
No

Timeline & Regulatory

Start
2009-12-10
Completion
2012-10-11

Countries

  • United States

Study Locations

More Related Trials

Entities

Diseases

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT01059214 on ClinicalTrials.gov